Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Century Therapeutics (IPSC) Shares Issued (2022 - 2025)

Historic Shares Issued for Century Therapeutics (IPSC) over the last 4 years, with Q1 2025 value amounting to $120000.0.

  • Century Therapeutics' Shares Issued fell 6721.31% to $120000.0 in Q1 2025 from the same period last year, while for Sep 2025 it was -$482000.0, marking a year-over-year decrease of 22454.78%. This contributed to the annual value of $141000.0 for FY2024, which is 7267.44% down from last year.
  • According to the latest figures from Q1 2025, Century Therapeutics' Shares Issued is $120000.0, which was down 6721.31% from -$602000.0 recorded in Q4 2024.
  • Century Therapeutics' Shares Issued's 5-year high stood at $26.8 million during Q1 2022, with a 5-year trough of -$602000.0 in Q4 2024.
  • For the 4-year period, Century Therapeutics' Shares Issued averaged around $2.8 million, with its median value being $198500.0 (2023).
  • In the last 5 years, Century Therapeutics' Shares Issued plummeted by 9832.92% in 2023 and then tumbled by 900.0% in 2024.
  • Over the past 4 years, Century Therapeutics' Shares Issued (Quarter) stood at $26.8 million in 2022, then plummeted by 101.33% to -$356000.0 in 2023, then crashed by 69.1% to -$602000.0 in 2024, then skyrocketed by 119.93% to $120000.0 in 2025.
  • Its last three reported values are $120000.0 in Q1 2025, -$602000.0 for Q4 2024, and $273000.0 during Q3 2024.